Format

Send to

Choose Destination
J Infect Dis. 2018 Apr 11;217(9):1356-1364. doi: 10.1093/infdis/jiy056.

Respiratory Syncytial Virus Seasonality: A Global Overview.

Author information

1
Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago.
2
GENVIP Research Group, Instituto de Investigación Sanitaria de Santiago, Santiago de Compostela, Galicia, Spain.
3
Children's Lung Environment and Asthma Research, Child Health Research Centre, University of Queensland, Brisbane, Queensland, Australia.
4
Respiratory syncytial virus network (ReSViNET), Zeist.
5
Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus.
6
Center for Vaccines and Immunity at Nationwide Children's Hospital, Ohio State University, Columbus.
7
Women's and Children's Health Department, University of Padova, Torino, Italy.
8
Department of Allergy, 2nd Pediatric Clinic, University of Athens, Greece.
9
Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Johannesburg, South Africa.
10
Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Johannesburg, South Africa.
11
Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
12
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of Witwatersrand, Johannesburg, South Africa.
13
Julius Clinical, University Medical Center Utrecht, Zeist.
14
Department of Pediatrics, University of Turku and Turku University Hospital, Finl.
15
MRC & Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, Johannesburg, South Africa.
16
Department of Women and Children's Health, School of Life Course Sciences.
17
Faculty of Life Sciences and Medicine, King's College London.
18
Pediatric Pulmonology Unit, Pontifícia Universidade Católica RS, Porto Alegre, Brazil.
19
Neonataology and Neonatal Intensive Care Unit, S Anna Hospital, Torino, Italy.
20
Department of Pediatrics, University Medical Center Utrecht, The Netherlands.
21
Laboratory of Translational Immunology, University Medical Center Utrecht, The Netherlands.

Abstract

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in children. By the age of 1 year, 60%-70% of children have been infected by RSV. In addition, early-life RSV infection is associated with the development of recurrent wheezing and asthma in infancy and childhood. The need for precise epidemiologic data regarding RSV as a worldwide pathogen has been growing steadily as novel RSV therapeutics are reaching the final stages of development. To optimize the prevention, diagnosis, and treatment of RSV infection in a timely manner, knowledge about the differences in the timing of the RSV epidemics worldwide is needed. Previous analyses, based on literature reviews of individual reports obtained from medical databases, have failed to provide global country seasonality patterns. Until recently, only certain countries have been recording RSV incidence through their own surveillance systems. This analysis was based on national RSV surveillance reports and medical databases from 27 countries worldwide. This is the first study to use original-source, high-quality surveillance data to establish a global, robust, and homogeneous report on global country-specific RSV seasonality.

PMID:
29390105
DOI:
10.1093/infdis/jiy056
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center